Phase II trial of rosuvastatin combined with chemoradiation therapy (CRT) in the treatment of high-risk locally advanced rectal cancer (STARC trial).

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览7
暂无评分
关键词
advanced rectal cancer,chemoradiation therapy,rosuvastatin,crt,high-risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要